← Back to Clinical Trials
Recruiting NCT04674969
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Trial Parameters
Condition Peripheral Vascular Diseases
Sponsor Boston Scientific Corporation
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-03-29
Completion 2028-01
Interventions
Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
Brief Summary
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
Eligibility Criteria
Inclusion Criteria: * Patients 18 years and older * Written informed consent (patient data release-form) * Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide Exclusion Criteria: * Life expectancy of \<1 year